Latest Articlesddd
Jazz Pharmaceuticals On September 9, 2025, Jazz Pharmaceuticals plc (JAZZ) announced that Modeyso™ (dordaviprone) is recommended by …
Xenon Pharmaceuticals A Company Treating Chronic Pain Xenon Pharmaceuticals (XENE) - a neuroscience-focused biopharmaceutical company dedicated …
Alnylam Pharmaceuticals Press Release Alnylam Pharmaceuticals, Inc. (ALNY), the leading RNAi therapeutics company, announced today that …
Regeneron Pharmaceuticals Announcement Late-breaking data from exploratory analyses at WCLC show Libtayo plus chemotherapy demonstrates a …
Alkermes in the NEWS Today, Alkermes Inc., (ALKS) announced detailed positive results from the Vibrance-1 phase …
Ionis Pharmaceuticals in the NEWS Today, Sep. 2, 2025, Ionis Pharmaceuticals (IONS) announced positive topline results …
Alnylam Pharmaceuticals Presentations In early September 2025, Alnylam Pharmaceuticals (ALNY) will present two investor conferences. The …
Approved COVID-19 Vaccines As of late August 2025, the U.S. Food and Drug Administration (FDA) has …
BioArtic AB & Novartis Sign Agreement Stockholm, Sweden, August 26, 2025 – BioArctic AB (publ) (Nasdaq …
One bad market day or more can help investors make it a good biotech market day. …
Ionis Pharmaceuticals Ionis Pharmaceuticals (IONS) announced that the U.S. FDA has approved DAWNZERA™ (donidalorsen) for prophylaxis …
Rhythm Pharmaceuticals in the NEWS Rhythm Pharmaceuticals, Inc. (RYTM) announced that the U.S. FDA has accepted …
Precigen in the NEWS Precigen (PGEN) announced that the United States (FDA) has approved the product PAPZIMEOS™ (zopapogene imadenovec-drba) …
Insmed Incorporated Today, investors must have realized the upward movement prices of the Viking Therapeutics (VKTX) …
Boehringer Ingelheim The following is not for investors but for people who love pets and want …
Akero Therapeutics Akero Therapeutics (AKRO) reported its Q22025 financial results for the period ending June 30, …
Gilead Sciences Reached Prohost Biotech's Target Gilead Sciences (GILD) reached our target of $120 today. Some …
Praxis Precision Medicines in the NEWS On Aug. 04, 2025, the biopharmaceutical company Praxis Precision Medicines …
Alnylam Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Period Progress The Financial Results …
AstraZeneca Imfinzi Based on MATTERHORN Phase III trial results which demonstrated a statistically significant and clinically …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
